Cleared Traditional

K241617 - Durex Polyisoprene Condom (FDA 510(k) Clearance)

Class II Obstetrics & Gynecology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2025
Decision
268d
Days
Class 2
Risk

K241617 is an FDA 510(k) clearance for the Durex Polyisoprene Condom. Classified as Condom, Synthetic (product code MOL), Class II - Special Controls.

Submitted by Rb Health (Us), LLC (Parsippany, US). The FDA issued a Cleared decision on February 28, 2025 after a review of 268 days - an extended review cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.5300 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Rb Health (Us), LLC devices

Submission Details

510(k) Number K241617 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 05, 2024
Decision Date February 28, 2025
Days to Decision 268 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
108d slower than avg
Panel avg: 160d · This submission: 268d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MOL Condom, Synthetic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.5300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - MOL Condom, Synthetic

All 21
Devices cleared under the same product code (MOL) and FDA review panel - the closest regulatory comparables to K241617.
ONE Nitrile Condom
K243967 · Global Protection Corp. · Apr 2025
TROJAN SIS Synthetic Latex Condom with Silicone Lubricant
K240379 · Church & Dwight Co., Inc. · Oct 2024
ONE Nitrile Condom
K240896 · Global Protection Corp. · Aug 2024
Polyisoprene Extra Large Condom
K232470 · Suretex Limited · May 2024
45 Micron Polyisoprene Condom
K231908 · Suretex Limited · Oct 2023
Okamoto 002 Lubricated Polyurethane Male Condom
K203541 · Okamoto USA, Inc. · Feb 2022